J.W. Cole Advisors Inc. Has $3.14 Million Holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI)

J.W. Cole Advisors Inc. decreased its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.6% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 35,179 shares of the exchange traded fund’s stock after selling 2,499 shares during the quarter. J.W. Cole Advisors Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,141,000 at the end of the most recent reporting period.

A number of other large investors have also recently bought and sold shares of the company. Roundview Capital LLC boosted its holdings in shares of SPDR S&P Biotech ETF by 275.4% in the 1st quarter. Roundview Capital LLC now owns 7,599 shares of the exchange traded fund’s stock valued at $683,000 after purchasing an additional 5,575 shares in the last quarter. U.S. Capital Wealth Advisors LLC bought a new stake in shares of SPDR S&P Biotech ETF during the 1st quarter worth $222,000. Synovus Financial Corp boosted its stake in SPDR S&P Biotech ETF by 559.1% in the first quarter. Synovus Financial Corp now owns 15,462 shares of the exchange traded fund’s stock valued at $1,390,000 after buying an additional 13,116 shares in the last quarter. Vontobel Holding Ltd. grew its position in SPDR S&P Biotech ETF by 6.7% in the first quarter. Vontobel Holding Ltd. now owns 6,400 shares of the exchange traded fund’s stock valued at $575,000 after acquiring an additional 400 shares during the last quarter. Finally, Sequoia Financial Advisors LLC grew its position in SPDR S&P Biotech ETF by 17.6% in the first quarter. Sequoia Financial Advisors LLC now owns 2,234 shares of the exchange traded fund’s stock valued at $201,000 after acquiring an additional 334 shares during the last quarter.

SPDR S&P Biotech ETF Stock Down 0.8 %

Shares of XBI stock traded down $0.65 on Friday, reaching $82.83. The company had a trading volume of 13,784,262 shares, compared to its average volume of 11,741,763. The business’s 50-day moving average is $93.52 and its 200 day moving average is $84.21. SPDR S&P Biotech ETF has a one year low of $63.80 and a one year high of $103.52. The stock has a market capitalization of $6.43 billion, a PE ratio of 11.47 and a beta of 1.08.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.